Revenue Summary of Beijing Aosaikang Pharmaceutical Co., Ltd.

Beijing Aosaikang Pharmaceutical Co., Ltd.'s latest annual revenue in 2023 was 1.44 Billion CNY , down -22.92% from previous year.
Beijing Aosaikang Pharmaceutical Co., Ltd.'s latest quarterly revenue in 2024 Q3 was 455.95 Million CNY , down -1.39% from previous quarter.
Beijing Aosaikang Pharmaceutical Co., Ltd. reported a annual revenue of 1.87 Billion CNY in annual revenue 2022, down -39.72% from previous year.
Beijing Aosaikang Pharmaceutical Co., Ltd. reported a annual revenue of 3.1 Billion CNY in annual revenue 2021, down -17.87% from previous year.
Beijing Aosaikang Pharmaceutical Co., Ltd. reported a quarterly revenue of 455.95 Million CNY for 2024 Q3, down -1.39% from previous quarter.
Beijing Aosaikang Pharmaceutical Co., Ltd. reported a quarterly revenue of 468.37 Million CNY for 2024 Q2, up 4.43% from previous quarter.

Annual Revenue Chart of Beijing Aosaikang Pharmaceutical Co., Ltd. (2023 - 2011)

Historical Annual Revenue of Beijing Aosaikang Pharmaceutical Co., Ltd. (2023 - 2011)

Year	Revenue	Revenue Growth
2023	1.44 Billion CNY	-22.92%
2022	1.87 Billion CNY	-39.72%
2021	3.1 Billion CNY	-17.87%
2020	3.78 Billion CNY	-16.29%
2019	4.51 Billion CNY	14.92%
2018	3.93 Billion CNY	974.48%
2017	365.93 Million CNY	105.17%
2016	178.35 Million CNY	-35.88%
2015	278.15 Million CNY	-40.93%
2014	470.86 Million CNY	-5.91%
2013	500.42 Million CNY	1.25%
2012	494.25 Million CNY	-6.6%
2011	529.17 Million CNY	0.0%

Year	Revenue	Revenue Growth
2024 Q1	448.49 Million CNY	38.55%
2024 Q3	455.95 Million CNY	-1.39%
2024 Q2	468.37 Million CNY	4.43%
2023 FY	1.44 Billion CNY	-22.92%
2023 Q3	407.89 Million CNY	9.27%
2023 Q2	373.29 Million CNY	10.26%
2023 Q4	323.71 Million CNY	-20.64%
2023 Q1	338.55 Million CNY	-7.59%
2022 Q1	535.53 Million CNY	-19.16%
2022 FY	1.87 Billion CNY	-39.72%
2022 Q3	495.66 Million CNY	4.35%
2022 Q4	366.38 Million CNY	-26.08%
2022 Q2	474.99 Million CNY	-11.3%
2021 Q4	662.42 Million CNY	-13.99%
2021 Q2	742.58 Million CNY	-20.28%
2021 Q1	931.46 Million CNY	-12.86%
2021 FY	3.1 Billion CNY	-17.87%
2021 Q3	770.19 Million CNY	3.72%
2020 Q2	793.03 Million CNY	11.81%
2020 Q3	1.21 Billion CNY	52.77%
2020 Q4	1.06 Billion CNY	-11.77%
2020 FY	3.78 Billion CNY	-16.29%
2020 Q1	709.23 Million CNY	-27.84%
2019 Q2	1.18 Billion CNY	6.65%
2019 FY	4.51 Billion CNY	14.92%
2019 Q4	982.92 Million CNY	-20.38%
2019 Q3	1.23 Billion CNY	3.95%
2019 Q1	1.11 Billion CNY	-69.07%
2018 FY	3.93 Billion CNY	974.48%
2018 Q3	105.99 Million CNY	-35.24%
2018 Q2	163.67 Million CNY	163.65%
2018 Q1	62.08 Million CNY	-49.28%
2018 Q4	3.6 Billion CNY	3296.44%
2017 Q1	32.15 Million CNY	-55.04%
2017 Q3	89.27 Million CNY	-26.88%
2017 Q2	122.09 Million CNY	279.67%
2017 FY	365.93 Million CNY	105.17%
2017 Q4	122.4 Million CNY	37.11%
2016 Q4	71.52 Million CNY	68.55%
2016 FY	178.35 Million CNY	-35.88%
2016 Q3	42.43 Million CNY	34.43%
2016 Q1	32.83 Million CNY	-52.64%
2016 Q2	31.56 Million CNY	-3.85%
2015 Q1	87.96 Million CNY	-50.82%
2015 Q4	69.32 Million CNY	152.04%
2015 Q3	27.5 Million CNY	-70.54%
2015 Q2	93.35 Million CNY	6.13%
2015 FY	278.15 Million CNY	-40.93%
2014 Q2	116.2 Million CNY	23.83%
2014 Q4	178.84 Million CNY	118.17%
2014 Q1	93.84 Million CNY	0.0%
2014 FY	470.86 Million CNY	-5.91%
2014 Q3	81.97 Million CNY	-29.46%
2013 Q3	748.47 Million CNY	20.17%
2013 Q2	622.84 Million CNY	0.0%
2013 Q1	622.84 Million CNY	13.55%
2013 FY	500.42 Million CNY	1.25%
2012 Q4	548.5 Million CNY	-2.71%
2012 FY	494.25 Million CNY	-6.6%
2012 Q3	563.78 Million CNY	0.0%
2011 FY	529.17 Million CNY	0.0%

Peer Revenue Comparison of Beijing Aosaikang Pharmaceutical Co., Ltd.

Name	Revenue	Revenue Difference
Shenzhen Kangtai Biological Products Co., Ltd.	3.47 Billion CNY	58.491%
PharmaBlock Sciences (Nanjing), Inc.	1.72 Billion CNY	16.331%
Shandong Shanda Wit Science and Technology Co., Ltd.	2.48 Billion CNY	41.894%
Pacific Shuanglin Bio-pharmacy Co., LTD	2.32 Billion CNY	38.015%
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd	1.46 Billion CNY	1.314%
Jilin Aodong Pharmaceutical Group Co., Ltd.	3.44 Billion CNY	58.15%
Chengdu Huasun Technology Group Inc., Ltd.	1 Billion CNY	-43.86%
Zhejiang AngLiKang Pharmaceutical CO.,LTD.	1.62 Billion CNY	11.219%
Hengkang Medical Group Co., Ltd.	3.59 Billion CNY	59.798%
Anhui Huangshan Capsule Co., Ltd.	458.36 Million CNY	-214.912%
Walvax Biotechnology Co., Ltd.	4.11 Billion CNY	64.912%
Tianjin Ringpu Bio-Technology Co.,Ltd.	2.24 Billion CNY	35.817%
Anhui Fengyuan Pharmaceutical Co., Ltd.	4.27 Billion CNY	66.238%
Apeloa Pharmaceutical Co.,Ltd	11.47 Billion CNY	87.42%
Harbin Gloria Pharmaceuticals Co., Ltd	2.58 Billion CNY	44.266%
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.	24.73 Billion CNY	94.165%
Hunan Hansen Pharmaceutical Co., Ltd.	955.53 Million CNY	-51.064%
Xiamen Kingdomway Group Company	3.1 Billion CNY	53.476%
Zhejiang Tianyu Pharmaceutical Co., Ltd.	2.52 Billion CNY	42.885%
Zhuhai Rundu Pharmaceutical Co., Ltd.	1.29 Billion CNY	-11.733%
Hainan Haiyao Co., Ltd.	1.45 Billion CNY	0.945%
Shenzhen Neptunus Bioengineering Co., Ltd.	36.41 Billion CNY	96.036%
Fujian Cosunter Pharmaceutical Co., Ltd.	422.71 Million CNY	-241.474%
Huapont Life Sciences Co., Ltd.	11.59 Billion CNY	87.551%
Livzon Pharmaceutical Group Inc.	12.27 Billion CNY	88.244%
Honz Pharmaceutical Co., Ltd.	739.56 Million CNY	-95.176%
Northeast Pharmaceutical Group Co., Ltd.	8.16 Billion CNY	82.314%
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.	5.42 Billion CNY	73.376%
Hainan Poly Pharm. Co., Ltd	1.3 Billion CNY	-10.654%
Sunflower Pharmaceutical Group Co.,Ltd	5.63 Billion CNY	74.369%
Zhejiang Jingxin Pharmaceutical Co., Ltd.	3.95 Billion CNY	63.476%
Kunming Longjin Pharmaceutical Co., Ltd.	86.62 Million CNY	-1566.379%
Zhejiang Hisoar Pharmaceutical Co., Ltd.	2.17 Billion CNY	33.539%
Zhejiang Yatai Pharmaceutical Co., Ltd.	420.64 Million CNY	-243.155%
Zhejiang NHU Company Ltd.	15.11 Billion CNY	90.451%
Zhejiang Xinguang Pharmaceutical Co., Ltd.	270.39 Million CNY	-433.824%
Jiuzhitang Co., Ltd.	2.91 Billion CNY	50.555%
Qianjiang Yongan Pharmaceutical Co., Ltd.	962.8 Million CNY	-49.922%
Jinghua Pharmaceutical Group Co., Ltd.	1.49 Billion CNY	3.153%
Hunan Er-Kang Pharmaceutical Co., Ltd	1.76 Billion CNY	18.412%
Yunnan Baiyao Group Co.,Ltd	38.9 Billion CNY	96.289%
ApicHope Pharmaceutical Co., Ltd	2.5 Billion CNY	42.341%
Shandong Wohua Pharmaceutical Co., Ltd.	894.31 Million CNY	-61.404%
Jinling Pharmaceutical Company Limited	2.78 Billion CNY	48.184%
Beijing SL Pharmaceutical Co., Ltd.	1.01 Billion CNY	-41.744%
Shanxi Zhendong Pharmaceutical Co.,Ltd	3.62 Billion CNY	60.192%
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd	980.82 Million CNY	-47.167%
Huaren Pharmaceutical Co., Ltd.	1.63 Billion CNY	11.783%
Betta Pharmaceuticals Co., Ltd.	2.45 Billion CNY	41.232%
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD	1.08 Billion CNY	-33.647%
Changzhou Qianhong Biopharma CO.,LTD	1.79 Billion CNY	19.534%
Chengdu Kanghong Pharmaceutical Group Co., Ltd	3.95 Billion CNY	63.526%
Changjiang Pharmaceutical Group Co., Ltd.	1.19 Billion CNY	-20.533%
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.	839.25 Million CNY	-71.992%
Zhejiang Garden Bio-chemical High-tech Co., Ltd.	1.09 Billion CNY	-31.865%
Tianjin Lisheng Pharmaceutical Co.,Ltd.	1.13 Billion CNY	-27.721%
Guangdong Lifestrong Pharmacy Co., Ltd.	292.39 Million CNY	-393.664%
Huadong Medicine Co., Ltd	40.39 Billion CNY	96.426%
PKU HealthCare Corp.,Ltd.	2.19 Billion CNY	34.203%
Hybio Pharmaceutical Co., Ltd.	431.38 Million CNY	-234.611%
Shenzhen Weiguang Biological Products Co., Ltd.	1.04 Billion CNY	-37.669%
Fuan Pharmaceutical (Group) Co., Ltd.	2.64 Billion CNY	45.484%
Jiangsu Nhwa Pharmaceutical Co., LTD	4.97 Billion CNY	70.977%
Harbin Medisan Pharmaceutical Co., Ltd.	1.18 Billion CNY	-21.628%
Teyi Pharmaceutical Group Co.,Ltd	1.06 Billion CNY	-35.255%
Tus-Pharmaceutical Group Co., Ltd.	395.92 Million CNY	-264.581%
LanZhou Foci Pharmaceutical Co.,Ltd.	1.16 Billion CNY	-24.101%
Changchun High-Tech Industries (Group) Inc.	14.46 Billion CNY	90.018%
Shanghai Kaibao Pharmaceutical CO.,Ltd	1.59 Billion CNY	9.447%
Shandong Xinhua Pharmaceutical Company Limited	8 Billion CNY	81.976%
Beijing Beilu Pharmaceutical Co., Ltd	890.71 Million CNY	-62.056%
Dezhan Healthcare Company Limited	498.08 Million CNY	-189.8%
Beijing Science Sun Pharmaceutical Co., Ltd.	476.56 Million CNY	-202.885%
Tianjin Chase Sun Pharmaceutical Co.,Ltd	6.12 Billion CNY	76.442%
Jinhe Biotechnology CO., LTD.	2.17 Billion CNY	33.608%
Baotou Dongbao Bio-Tech Co.,Ltd	974.51 Million CNY	-48.121%
ShanXi C&Y Pharmaceutical Group Co., Ltd.	799.3 Million CNY	-80.589%
Tibet AIM Pharm. Inc.	667.03 Million CNY	-116.398%
Guangdong Zhongsheng Pharmaceutical Co., Ltd.	2.61 Billion CNY	44.707%
Nanjing Hicin Pharmaceutical Co., Ltd.	517.83 Million CNY	-178.75%
Renhe Pharmacy Co., Ltd.	5.03 Billion CNY	71.315%
Wuhan Hiteck Biological Pharma Co.,Ltd	602.28 Million CNY	-139.664%
Guizhou Xinbang Pharmaceutical Co., Ltd.	6.46 Billion CNY	77.658%
Dong-E-E-Jiao Co.,Ltd.	4.71 Billion CNY	69.388%
Jiangxi Synergy Pharmaceutical Co., Ltd.	722.13 Million CNY	-99.887%
Chongqing Pharscin Pharmaceutical Co., Ltd.	691.54 Million CNY	-108.73%
Zhejiang Xianju Pharmaceutical Co.,Ltd.	4.12 Billion CNY	64.994%
Luoxin Pharmaceuticals Group Stock Co., Ltd.	2.34 Billion CNY	38.383%
Guizhou Bailing Group Pharmaceutical Co., Ltd.	4.26 Billion CNY	66.14%

Global Stocks Search

Beijing Aosaikang Pharmaceutical Co., Ltd. (002755.SZ)

Revenue Summary of Beijing Aosaikang Pharmaceutical Co., Ltd.

Annual Revenue Chart of Beijing Aosaikang Pharmaceutical Co., Ltd. (2023 - 2011)

Historical Annual Revenue of Beijing Aosaikang Pharmaceutical Co., Ltd. (2023 - 2011)

Peer Revenue Comparison of Beijing Aosaikang Pharmaceutical Co., Ltd.